Waystar, recently IPO'd, initiated at Buy by Barclays and RBC with 25% upside potential

From Investing.com: 2024-07-03 08:40:04

Several investment firms, including Barclays and RBC Capital Markets, have initiated research coverage on Waystar Holding (WAY) after its recent IPO. Barclays gave WAY an Overweight rating with a $24 price target, highlighting the company’s durability in the health tech sector. RBC Capital Markets also rated WAY Outperform with a $27 price target, noting its leadership in revenue cycle software. All 10 analysts covering WAY have rated it a Buy.



Read more at Investing.com: Waystar initiated at Buy at Barclays and RBC, upside potential up to 25% By Investing.com